Deferasirox
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01609 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 50 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | HIV infectious disease | KG + DL |
| 2 | chronic hepatitis C virus infection | KG + DL |
| 3 | neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter | KG + DL |
| 4 | obsolete familial combined hyperlipidemia | KG + DL |
| 5 | dermatofibrosarcoma protuberans | KG + DL |
| 6 | feline acquired immunodeficiency syndrome | KG + DL |
| 7 | simian immunodeficiency virus infection | KG + DL |
| 8 | beta-thalassemia with other manifestations | KG + DL |
| 9 | pyropoikilocytosis, hereditary | KG + DL |
| 10 | pyruvate kinase deficiency of red cells | KG + DL |
| 11 | sitosterolemia | KG + DL |
| 12 | Plasmodium falciparum malaria | KG + DL |
| 13 | homozygous familial hypercholesterolemia | KG + DL |
| 14 | partial deletion of the short arm of chromosome 16 | KG + DL |
| 15 | hemolytic anemia due to glucophosphate isomerase deficiency | KG + DL |
| 16 | gout | KG + DL |
| 17 | fibroblastic neoplasm | KG + DL |
| 18 | hepatitis B virus infection | KG + DL |
| 19 | conventional fibrosarcoma | KG + DL |
| 20 | kidney fibrosarcoma | KG + DL |
| 21 | heart fibrosarcoma | KG + DL |
| 22 | low grade fibromyxoid sarcoma | KG + DL |
| 23 | chronic hepatitis B virus infection | KG + DL |
| 24 | autosomal recessive familial Mediterranean fever | KG + DL |
| 25 | hepatitis C virus infection | KG + DL |
| 26 | hypercholesterolemia, autosomal dominant | KG + DL |
| 27 | paratenonitis | KG + DL |
| 28 | calcific tendinitis | KG + DL |
| 29 | fetal methylmercury syndrome | KG + DL |
| 30 | hepatitis, viral, animal | KG + DL |
| 31 | liver fibrosarcoma | KG + DL |
| 32 | hepatitis E virus infection | KG + DL |
| 33 | Omsk hemorrhagic fever | KG + DL |
| 34 | hepatitis A virus infection | KG + DL |
| 35 | Kyasanur forest disease | KG + DL |
| 36 | familial hypercholesterolemia | KG + DL |
| 37 | carotid artery thrombosis | KG + DL |
| 38 | hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome | KG + DL |
| 39 | infantile mercury poisoning | KG + DL |
| 40 | diarrheal disease | KG + DL |
| 41 | blepharo-cheilo-odontic syndrome | KG + DL |
| 42 | benign PEComa | KG + DL |
| 43 | spherocytosis | KG + DL |
| 44 | uterine corpus perivascular epithelioid cell tumor | KG + DL |
| 45 | lymphangiomyoma | KG + DL |
| 46 | bone fibrosarcoma | KG + DL |
| 47 | sickle cell anemia | KG + DL |
| 48 | carotid stenosis | KG + DL |
| 49 | female breast carcinoma | KG + DL |
| 50 | myositis | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.